Excited to share my first PhD research pre-print! Pharmacogenomics has the potential to guide more personalised prescribing, but how informative are common pharmacogenetic markers for medications used in chronic pain? www.linkedin.com/posts/giovan...
Evaluating the Clinical Impact of CYP2C19 and CYP2D6 on Amitriptyline Outcomes in a Real-World Chronic Pain Cohort | Giovanni Ferreira
Pharmacogenomics is often promoted as a way to personalise treatment, but how useful is it for medicines commonly used in chronic pain? In a new preprint, we examined whether variation in the CYP2C19...
linkedin.com